Novel Low Cost Bubble CPAP as an Alternative Respiratory Support in Low Resource Setting

NCT ID: NCT06082674

Last Updated: 2023-10-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single-blind randomized controlled trial done in a Level III neonatal intensive care unit. Preterm newborns with RDS were randomized to receive oxygen therapy through bubble CPAP vs ventilator-derived CPAP. Differences in arterial blood gases, oxygen saturation, number of surfactant and CPAP failure rate between study groups were analyzed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background and Objective: Respiratory distress syndrome (RDS) among premature infants is one of the major causes of neonatal death. The use of continuous positive airway pressure (CPAP) has become a standard of care for preterm newborns with RDS. In countries faced with the challenge of improving neonatal care, cost-effective innovations for respiratory support are a promising intervention. This study determined the efficacy of a low-cost bubble CPAP as an alternative non-invasive oxygen therapy for newborn infants with RDS.

METHODS: This is a single-blind randomized controlled trial done in a Level III neonatal intensive care unit. Preterm newborns with RDS were randomized to receive oxygen therapy through bubble CPAP vs ventilator-derived CPAP. Differences in arterial blood gases, oxygen saturation, number of surfactant and CPAP failure rate between study groups were analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Respiratory Distress Syndrome in Premature Infant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
The study Blinded the investigator and outcome assesors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vayu CPAP Group

The patients will be hooked to VAYu bCPAP

Group Type EXPERIMENTAL

Vayu bCPAP

Intervention Type DEVICE

The Vayu bCPAP uses a constant flow of dry oxygen from the source with an adjustable flow meter. Oxygen is blended by Venturi blender with ambient air to create a source of oxygen-enriched air of adjustable concentration.

Mechanical Ventilator Driven CPAP

Patients will be hooked to Mechanical Ventilator Driven CPAP

Group Type ACTIVE_COMPARATOR

Mechanical Ventilator Driven CPAP

Intervention Type DEVICE

Mechanical Ventilator Driven CPAP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vayu bCPAP

The Vayu bCPAP uses a constant flow of dry oxygen from the source with an adjustable flow meter. Oxygen is blended by Venturi blender with ambient air to create a source of oxygen-enriched air of adjustable concentration.

Intervention Type DEVICE

Mechanical Ventilator Driven CPAP

Mechanical Ventilator Driven CPAP

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Included are preterm neonates less than 36 weeks (WHO definition)
* admitted at NICU
* APGAR scores of \> 7 in the 1st and 5th minute of life
* in respiratory distress at birth,
* radiologic findings of RDS
* Respiratory Severity Score (RSS) or Downe's score \> 4 at 10-15 minutes after hooking to CPAP
* requiring CPAP or more than 40% FiO2

Exclusion Criteria

* Infants requiring neonatal resuscitation such as bag mask ventilation, chest compression or intubation at birth
* with comorbidities such as facial anomalies, tracheoesophageal fistulas, congenital heart disease, and other congenital anomalies which may interfere with the interface of both devices.
Minimum Eligible Age

5 Minutes

Maximum Eligible Age

6 Hours

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ilocos Training and Regional Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Navid Roodaki

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Navid Roodaki, MD

Role: PRINCIPAL_INVESTIGATOR

Ilocos Training and Regional Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ilocos Training and Regional Medical Center

San Fernando City, La Union, Philippines

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Philippines

References

Explore related publications, articles, or registry entries linked to this study.

Badin S, Roodaki N, Garcia DEC, Abila-Cariaga R, Burke TF. Evaluation of a novel reprocessed bCPAP system on sepsis rates among preterm neonates with respiratory distress: a randomized controlled trial. Front Pediatr. 2025 May 19;13:1569437. doi: 10.3389/fped.2025.1569437. eCollection 2025.

Reference Type DERIVED
PMID: 40458453 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ITRMC-REC-2022-11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.